CRISPR/Cas9 targeting of passenger single nucleotide variants in haploinsufficient or essential genes expands cancer therapy prospects
Nakyoung Lee(Yonsei University), Seung‐Bin Cha(Yonsei University), Myung Joon Oh(Yonsei University), Seung-il Jo(Yonsei University), Hyun Seok Kim(Ewha Womans University), Minjee Kim(Massachusetts Eye and Ear Infirmary), Jang Hee Han(Yonsei University), Hyosil Kim(Yonsei University), GaWon Choi(Yonsei University)
Cited by 3
Related Papers
Snail acetylation by autophagy‐derived acetyl‐coenzyme A promotes invasion and metastasis of <i>KRAS</i> ‐ <i>LKB1</i> co‐mutated lung cancer cells
|Cancer Communications|2022|66
Brain Distribution of a Panel of Epidermal Growth Factor Receptor Inhibitors Using Cassette Dosing in Wild-Type and Abcb1/Abcg2-Deficient Mice
|Drug Metabolism and Disposition|2019|49
Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood–Brain Barrier
|Molecular Cancer Therapeutics|2018|40
Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
|Cancer Research|2022|17
Mitigation of Effect Modification by Psychological Status in Patients With Hearing Loss
|JAMA Otolaryngology–Head & Neck Surgery|2024|16